Emmanuela Gakidou
A5037038907- Global Maternal and Child Health
- Global Public Health Policies and Epidemiology
- Global Health Care Issues
- Healthcare Systems and Reforms
- Health disparities and outcomes
- Climate Change and Health Impacts
- Healthcare Policy and Management
- Child Nutrition and Water Access
- Health Systems, Economic Evaluations, Quality of Life
- HIV/AIDS Research and Interventions
- Poverty, Education, and Child Welfare
- COVID-19 epidemiological studies
- Smoking Behavior and Cessation
- HIV/AIDS Impact and Responses
- Obesity, Physical Activity, Diet
- Insurance, Mortality, Demography, Risk Management
- Alcohol Consumption and Health Effects
- Nutritional Studies and Diet
- Primary Care and Health Outcomes
- Food Security and Health in Diverse Populations
- Substance Abuse Treatment and Outcomes
- COVID-19 Pandemic Impacts
- Air Quality and Health Impacts
- Chronic Disease Management Strategies
- Health Promotion and Cardiovascular Prevention
Institute for Health Metrics and Evaluation
2016-2025
University of Washington
2015-2024
Seattle University
2016-2022
Sapienza University of Rome
2020
Center For Reconstructive Urethral Surgery
2020
Bangladesh University of Health Sciences
2020
Tehran University of Medical Sciences
2020
UNSW Sydney
2018
Universidad de la República
2017
Karolinska Institutet
2017
BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to factor quantification that offers useful tool for synthesising evidence on risks risk–outcome associations. With each annual GBD study, we update the CRA incorporate improved methods, new pairs, data exposure levels associations.MethodsWe used framework developed previous iterations estimate trends in exposure, attributable deaths,...
BackgroundPublic health is a priority for the Chinese Government. Evidence-based decision making at province level in China, which home to fifth of global population, paramount importance. This analysis uses data from Global Burden Diseases, Injuries, and Risk Factors Study (GBD) 2017 help inform monitor progress on level.MethodsWe used methods GBD analyse patterns 34 province-level administrative units China 1990 2017. We estimated all-cause cause-specific mortality, years life lost (YLLs),...
BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment risk factor exposure attributable burden disease. By providing estimates over long time series, this study can monitor trends critical to health surveillance inform policy debates on the importance addressing risks in context.MethodsWe used comparative framework developed for previous iterations GBD estimate levels exposure, deaths, disability-adjusted life-years...
<h3>Importance</h3> Tobacco is a leading global disease risk factor. Understanding national trends in prevalence and consumption critical for prioritizing action evaluating tobacco control progress. <h3>Objective</h3> To estimate the of daily smoking by age sex number cigarettes per smoker day 187 countries from 1980 to 2012. <h3>Design</h3> Nationally representative sources that measured use (n = 2102 country-years data) were systematically identified. Survey data did not report adjusted...
Emmanuela Gakidou and colleagues find that coverage of cervical cancer screening in developing countries is on average 19% compared to 63% developed countries.
Alcohol and drug use can have negative consequences on the health, economy, productivity, social aspects of communities. We aimed to data from Global Burden Diseases, Injuries, Risk Factors Study (GBD) 2016 calculate global regional estimates prevalence alcohol, amphetamine, cannabis, cocaine, opioid dependence, estimate disease burden attributable alcohol between 1990 2016, for 195 countries territories within 21 regions, seven super-regions. also examine association Socio-demographic Index...
18% of the world's population lives in India, and many states India have populations similar to those large countries. Action effectively improve health requires availability reliable comprehensive state-level estimates disease burden risk factors over time. Such not been available so far for all major diseases factors. Thus, we aimed estimate every state as part Global Burden Disease (GBD) Study 2016.Using data sources, State-Level Initiative estimated (metrics were deaths,...
Timely assessment of the burden HIV/AIDS is essential for policy setting and programme evaluation. In this report from Global Burden Disease Study 2015 (GBD 2015), we provide national estimates levels trends incidence, prevalence, coverage antiretroviral therapy (ART), mortality 195 countries territories 1980 to 2015.For without high-quality vital registration data, estimated prevalence incidence with data antenatal care clinics population-based seroprevalence surveys, assumptions by age sex...
Abstract We use COVID-19 case and mortality data from 1 February 2020 to 21 September a deterministic SEIR (susceptible, exposed, infectious recovered) compartmental framework model possible trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections the effects non-pharmaceutical interventions in United States at state level 22 through 28 2021. Using this model, projections critical driving covariates (pneumonia seasonality, mobility, testing rates mask per...
National rates of COVID-19 infection and fatality have varied dramatically since the onset pandemic. Understanding conditions associated with this cross-country variation is essential to guiding investment in more effective preparedness response for future pandemics.
BackgroundUniversally, smoking cessation rates among established smokers are poor. Preventing young people from starting use of and becoming addicted to tobacco products remains a key strategy end the epidemic. Previous country-specific studies have found that initiation occurs predominantly mixed progress in reducing prevalence people. Current comparable estimates for all countries needed inform targeted interventions policies.MethodsWe modelled two indicators: current adults aged 15–24...
Background Despite compelling evidence on the health hazards of tobacco products accumulated over past 70 years, smoking remains a leading cause death worldwide. Policy action to control requires timely, comprehensive, and comparable levels within across countries. This study provides recent assessment that based methods used in Global Burden Disease (GBD) Study. Methods We estimated annual prevalence of, mortality attributable any form from 1970 2020 1990–2020, respectively, using data...
Timely, accurate, and comprehensive estimates of SARS-CoV-2 daily infection rates, cumulative infections, the proportion population that has been infected at least once, effective reproductive number (R